Usefulness of indirect noninvasive methods in predicting progression to cirrhosis in chronic hepatitis C.

BACKGROUND AND AIMS: The ability of noninvasive methods to predict the development of cirrhosis has not been established. We evaluated the ability of three noninvasive methods [the Forns index, the aspartate aminotransferase-to-platelet ratio index (APRI), and the Non-Invasive Hepatitis-C-related Cirrhosis Early Detection (NIHCED) score] to determine the risk of developing cirrhosis in chronic hepatitis C. METHODS: Consecutive patients with chronic hepatitis C who had undergone liver biopsy between 1998 and 2004 were eligible. We used the three methods to evaluate patients at baseline and at follow-up (4-10 years later). When these methods yielded discordant or indeterminate results, a second liver biopsy was performed. Logistic regression models were fitted for each method to predict whether cirrhosis would appear and to predict long-term mortality from cirrhosis. RESULTS: We included 289 patients in our study. The mean scores at baseline and at follow-up, respectively, were as follows: Forns, 5.47 ± 1.95 and 6.56 ± 2.02; APRI, 1.1 ± 2.33 and 1.4 ± 1.53; and NIHCED, 7.79 ± 11.45 and 15.48 ± 15.28. The area under the receiver operating characteristic curve for predicting cirrhosis was 0.83 for Forns, 0.79 for APRI, and 0.76 for NIHCED. The sensitivity and specificity for predicting cirrhosis, respectively, were 75 and 71% for Forns (cutoff 4.7), 86 and 42% for APRI (cutoff 0.48), and 41 and 82% for NIHCED (cutoff 0). The area under the receiver operating characteristic curve for predicting mortality was 0.86 for Forns, 0.79 for APRI, and 0.84 for NIHCED. CONCLUSION: Indirect noninvasive markers could help identify patients with chronic hepatitis C at risk of progression to cirrhosis.

Effectiveness of rituximab in severe Wegener's granulomatosis: report of two cases and review of the literature.

We hereby describe the satisfactory evolution of rituximab treatment in two patients with Wegener's granulomatosis (WG). Rituximab was indicated for refractoriness to standard treatment in one case and life-threatening myelotoxicity due to alkylating agents in the other. A brief review of previous experience with the use of rituximab in the treatment of WG is presented.

[Infectious osteitis pubis]. / Osteítis infecciosa del pubis.

INTRODUCTION: Infectious osteitis pubis is an uncommon disease that must be distinguished from the noninfectious form of this condition. METHODS: Four cases of infectious osteitis pubis diagnosed over the last ten years in our hospital are described. RESULTS: The diagnosis was established on the basis of clinical symptoms, consistent imaging studies, and positive blood cultures (2/4) or bone biopsy (2/4). Prolonged antibiotic treatment with previous debridement of abscesses provided favorable outcomes (4/4). CONCLUSION: Infectious osteitis pubis should be suspected in patients with groin pain and predisposing factors.

Osteítis infecciosa del pubis / Infectious osteitis pubis

INTRODUCCIÓN. La osteítis infecciosa del pubis es una entidad poco frecuente que debe diferenciarse de su formano infecciosa. MÉTODOS. Descripción de cuatro casos de osteítis infecciosa del pubis diagnosticados en los últimos 10 años en nuestro centro. RESULTADOS. El diagnóstico se estableció mediante clínica e imagen sugestiva junto con hemocultivos positivos (2/4) o por biopsia ósea (2/4). La antibioticoterapia prolongada, con desbridamiento en caso de absceso, ofreció resultados satisfactorios (4/4).CONCLUSIÓN. La osteítis infecciosa del pubis debe sospecharse en pacientes con dolor inguinal y factores predisponentes (AU)

INTRODUCTION. Infectious osteitis pubis is an uncommon disease that must be distinguished from the non-infectious form of this condition. METHODS. Four cases of infectious osteitis pubis diagnosed over the last ten years in our hospital are described. RESULTS. The diagnosis was established on the basis of clinical symptoms, consistent imaging studies, and positive blood cultures (2/4) or bone biopsy (2/4).Prolonged antibiotic treatment with previous debridement of abscesses provided favorable outcomes (4/4).CONCLUSION. Infectious osteitis pubis should be suspected in patients with groin pain and predisposing factors (AU)